Figures computed from official regulatory filings — .
Analysttarget 5.56 USD (-5%) · consensus 3.75/5 · 2 buy · 2 hold · 0 sell
Ownershipinsiders 8.47% · institutions 62.95% · short 5.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Cytek Biosciences, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
27 buys75 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| McCombe William D. | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| MUIR GLENN Ptrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Yan Ming | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Jiang Wenbin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Jiang Wenbin | Other | $25.1K | SEC | ||
| McCombe William D. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Yan Ming | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Yan Ming | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| McCombe William D. | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Jiang Wenbin | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Jiang Wenbin | Other | $13.4K | SEC | ||
| Yan Ming | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| McCombe William D. | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Chin Richardtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Jiang Wenbin | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Jiang Wenbin | Other | $97.9K | Unusual size | SEC | |
| Yan Ming | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
| Yan Ming | Other | $6.3K | SEC | ||
| McCombe William D. | Other | $25.2K | SEC | ||
| Yan Ming | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Holder Michael | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Jiang Wenbin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Yan Ming | Other | $8.3K | SEC | ||
| McCombe William D. | Other | $9.9K | SEC | ||
| Jiang Wenbin | Exercise | n/a (No price was disclosed in the filing) | SEC |